Explore more publications!
Tonga Healthcare Daily
Submit Press Release

Tonga Healthcare Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tonga Healthcare Daily.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on November 19, 2025

Profusa Announces Third Quarter Business and Financial Highlights
November 19, 2025

Profusa Announces Third Quarter Business and Financial Highlights

Indeterminate GlobeNewswire
Apollomics Announces Settlement of Cayman Litigation
November 19, 2025

Apollomics Announces Settlement of Cayman Litigation

Indeterminate GlobeNewswire
Extendicare to Expand its Home Health Care Business by Acquiring CBI Home Health for $570 Million in Cash Consideration
November 19, 2025

Extendicare to Expand its Home Health Care Business by Acquiring CBI Home Health for $570 Million in Cash Consideration

Indeterminate GlobeNewswire
FDA Pilots Faster Clarifications to Meeting Minutes
November 19, 2025

FDA Pilots Faster Clarifications to Meeting Minutes

Indeterminate GlobeNewswire
Heartflow to Participate in the Piper Sandler 37th Annual Healthcare Conference
November 19, 2025

Heartflow to Participate in the Piper Sandler 37th Annual Healthcare Conference

Indeterminate GlobeNewswire
Arch Biopartners Closes Non-Brokered Private Placement
November 19, 2025

Arch Biopartners Closes Non-Brokered Private Placement

Indeterminate GlobeNewswire
Vivos Therapeutics Reports Significant Revenue Growth During the Third Quarter 2025
November 19, 2025

Vivos Therapeutics Reports Significant Revenue Growth During the Third Quarter 2025

Indeterminate GlobeNewswire
ZyVersa Therapeutics Reports Third Quarter 2025 Financial Results
November 19, 2025

ZyVersa Therapeutics Reports Third Quarter 2025 Financial Results

Indeterminate GlobeNewswire
EYLEA HD® (aflibercept) Injection 8 mg Approved by FDA for the Treatment of Macular Edema Following Retinal Vein Occlusion (RVO) and for Monthly Dosing Across Approved Indications
November 19, 2025

EYLEA HD® (aflibercept) Injection 8 mg Approved by FDA for the Treatment of Macular Edema Following Retinal Vein Occlusion (RVO) and for Monthly Dosing Across Approved Indications

Indeterminate GlobeNewswire
Ceribell to Participate in the Piper Sandler 37th Annual Healthcare Conference
November 19, 2025

Ceribell to Participate in the Piper Sandler 37th Annual Healthcare Conference

Indeterminate GlobeNewswire
SynCardia Completes First In Vivo Implantations of Next-Generation Emperor Total Artificial Heart
November 19, 2025

SynCardia Completes First In Vivo Implantations of Next-Generation Emperor Total Artificial Heart

Indeterminate GlobeNewswire
OPKO Health to Participate in the Piper Sandler 37th Annual Healthcare Conference
November 19, 2025

OPKO Health to Participate in the Piper Sandler 37th Annual Healthcare Conference

Indeterminate GlobeNewswire
Meihua International Announces 1-For-100 Reverse Share Split
November 19, 2025

Meihua International Announces 1-For-100 Reverse Share Split

Indeterminate GlobeNewswire
ImPact Biotech to Present Updated Interim Phase 3 Data from ENLIGHTED Study of Padeliporfin VTP in Low Grade UTUC at SUO 2025
November 19, 2025

ImPact Biotech to Present Updated Interim Phase 3 Data from ENLIGHTED Study of Padeliporfin VTP in Low Grade UTUC at SUO 2025

Indeterminate GlobeNewswire
Carlsmed, Inc. To Participate in the Piper Sandler 37th Annual Healthcare Conference
November 19, 2025

Carlsmed, Inc. To Participate in the Piper Sandler 37th Annual Healthcare Conference

Indeterminate GlobeNewswire
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
November 19, 2025

BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Patriot Mobile Named SoldierStrong’s 2025 Corporate Recipient of the Annual Commitment to Service Award
November 19, 2025

Patriot Mobile Named SoldierStrong’s 2025 Corporate Recipient of the Annual Commitment to Service Award

Indeterminate GlobeNewswire
First Look at Roche/Genentech’s Gazyva Shows Strong Early Enthusiasm in Lupus Nephritis Launch, According to Spherix Global Insights
November 19, 2025

First Look at Roche/Genentech’s Gazyva Shows Strong Early Enthusiasm in Lupus Nephritis Launch, According to Spherix Global Insights

Indeterminate GlobeNewswire
Vista Physical Therapy Expands North Texas Footprint With Two New Outpatient Clinics in Rockwall and Frisco
November 19, 2025

Vista Physical Therapy Expands North Texas Footprint With Two New Outpatient Clinics in Rockwall and Frisco

Indeterminate GlobeNewswire
Salarius Pharmaceuticals Cites Errors on S&P CapIQ Platform Following Merger with Decoy Therapeutics, Affirms Its Shares Continue to Trade on the Nasdaq Stock Market Under the Symbol “SLRX”
November 19, 2025

Salarius Pharmaceuticals Cites Errors on S&P CapIQ Platform Following Merger with Decoy Therapeutics, Affirms Its Shares Continue to Trade on the Nasdaq Stock Market Under the Symbol “SLRX”

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions